On Jan. 10, 2022, the Departments of Labor, Treasury and Health and Human Services released guidance to support the Administration’s directive that health insurers and group health plans cover the cost of FDA-authorized or approved over-the-counter (OTC) at-home COVID-19 tests purchased on or after Jan. 15, 2022.
Beginning Jan. 15, 2022, UnitedHealthcare will cover most commercial individual and group plan members’ FDA authorized and approved OTC at-home COVID-19 diagnostic tests purchased on or after this date, without a doctor’s prescription or clinical assessment. This at-home COVID-19 test coverage will include up to 8 tests per member per 30 days.
For more information, please see UHC's COVID-19 OTC at Home Testing FAQs.
For questions or help with a UHC Specialty quote, please contact a member of your B&P Sales Team - 888.722.3373.